Mitigate risks of medication interruption due to COVID‐19 for elderly with chronic diseases

por Hsiao, Shih‐Huai, Chang, Hsiu‐Mei, Kang, Ya‐Ting, Chen, Yen‐Hsu
Publicado 2020

The effect of lung recruitment maneuverer in COVID‐19 induced acute respiratory distress syndrome

por Lin, Wei‐Chiang, Lin, Shang‐Yi, Tsai, Meng‐Che, Chung, Fu‐Tsai, Chang, Hsiu‐Mei
Publicado 2023

Using a Text Mining Approach to Explore the Recording Quality of a Nursing Record System

por CHANG, Hsiu-Mei, HUANG, Ean-Weng, HOU, I-Ching, LIU, Hsiu-Yun, LI, Fang-Shan, CHIOU, Shwu-Fen
Publicado 2019

Comparative Efficacy and Safety of P2Y12 Inhibitor Monotherapy and Dual Antiplatelet Therapy in Patients with and without Diabetes Mellitus Undergoing Percutaneous Coronary Interve...

por Feng, Wen-Han, Chang, Yong-Chieh, Lin, Yi-Hsiung, Chen, Hsiao-Ling, Chang, Hsiu-Mei, Chu, Chih-Sheng
Publicado 2022

Clinic image surveillance reduces mortality in patients with primary hepato-gastrointestinal cancer who develop second primary lung cancer: A STROBE-compliant retrospective study

por Huang, Hung-Yu, Lu, Min-Wei, Chen, Mei-Chi, Chang, Hsiu-Mei, Kuo, Chih-Hsi, Lin, Shu-Min, Wang, Chun-Hua, Chung, Fu-Tsai
Publicado 2020

Immune Checkpoints Inhibitors and Chemotherapy as First-Line Treatment for Metastatic Urothelial Carcinoma: A Network Meta-Analysis of Randomized Phase III Clinical Trials

por Chen, Hsiao-Ling, Chan, Vinson Wai-Shun, Tu, Yu-Kang, Chan, Erica On-Ting, Chang, Hsiu-Mei, Juan, Yung-Shun, Teoh, Jeremy Yuen-Chun, Lee, Hsiang Ying
Publicado 2021

Systematic Review and Network Meta-Analysis of Immune Checkpoint Inhibitors in Combination with Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Carcinoma

por Chen, Hsiao-Ling, Tu, Yu-Kang, Chang, Hsiu-Mei, Lee, Tai-Huang, Wu, Kuan-Li, Tsai, Yu-Chen, Lee, Mei-Hsuan, Yang, Chih-Jen, Hung, Jen-Yu, Chong, Inn-Wen
Publicado 2020

Salvage Therapy for Relapsed Malignant Pleural Mesothelioma: A Systematic Review and Network Meta-Analysis

por Tsai, Yu-Chen, Chen, Hsiao-Ling, Lee, Tai-Huang, Chang, Hsiu-Mei, Wu, Kuan-Li, Chuang, Cheng-Hao, Chang, Yong-Chieh, Tu, Yu-Kang, Hung, Jen-Yu, Yang, Chih-Jen, Chong, Inn-Wen
Publicado 2021

P2Y12 Inhibitor Monotherapy versus Conventional Dual Antiplatelet Therapy in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: A Meta-Analysis

por Feng, Wen-Han, Chang, Yong-Chieh, Lin, Yi-Hsiung, Chen, Hsiao-Ling, Chen, Chun-Yin, Lin, Tsung-Han, Lin, Tzu-Chieh, Chang, Ching-Tang, Kuo, Hsuan-Fu, Chang, Hsiu-Mei, Chu, Chih-Sheng
Publicado 2023

First-Line Anaplastic Lymphoma Kinase (ALK) Inhibitors for ALK-Positive Lung Cancer in Asian Populations: Systematic Review and Network Meta-Analysis

por Wu, Kuan-Li, Chen, Hsiao-Ling, Tsai, Ying-Ming, Lee, Tai-Huang, Chang, Hsiu-Mei, Tsai, Yu-Chen, Chuang, Cheng-Hao, Chang, Yong-Chieh, Tu, Yu-Kang, Yang, Chih-Jen, Hung, Jen-Yu, Chong, Inn-Wen
Publicado 2021

Impact of Smoking Status in Combination Treatment with EGFR Tyrosine Kinase Inhibitors and Anti-Angiogenic Agents in Advanced Non-Small Cell Lung Cancer Harboring Susceptible EGFR...

por Lee, Tai-Huang, Chen, Hsiao-Ling, Chang, Hsiu-Mei, Wu, Chiou-Mei, Wu, Kuan-Li, Kuo, Chia-Yu, Wei, Po-Ju, Chen, Chin-Ling, Liu, Hui-Lin, Hung, Jen-Yu, Yang, Chih-Jen, Chong, Inn-Wen
Publicado 2022

Systematic Review and Network Meta-Analysis of Anaplastic Lymphoma Kinase (ALK) Inhibitors for Treatment-Naïve ALK-Positive Lung Cancer

por Chuang, Cheng-Hao, Chen, Hsiao-Ling, Chang, Hsiu-Mei, Tsai, Yu-Chen, Wu, Kuan-Li, Chen, I-Hua, Chen, Kung-Chao, Lee, Jui-Ying, Chang, Yong-Chieh, Chen, Chin-Ling, Tu, Yu-Kang, Hung, Jen-Yu, Yang, Chih-Jen, Chong, Inn-Wen
Publicado 2021